论文部分内容阅读
目的:观察米非司酮联合甲氨蝶呤保守治疗异位妊娠患者的实际疗效,探讨该治疗方案的临床应用价值。方法:选择2016年3月至2016年9月我院收治的60例异位妊娠患者,按照随机原则分为例数相等的观察组(n=30)及对照组(n=30),其中观察组给予米非司酮联合甲氨蝶呤保守治疗;对照组单用甲氨蝶呤保守治疗。结果:观察组有效28例,无效2例,有效率93.3%(28/30),对照组有效20例,无效10例,有效率66.7%(20/30),观察组及对照组有效率组间差异具有统计学意义(p<0.05)。结论:米非司酮联合甲氨蝶呤保守治疗用于异位妊娠的临床治疗,显著提升了疗效,具有较高的应用价值,值得临床推广应用。
Objective: To observe the curative effect of conservative treatment of ectopic pregnancy with mifepristone and methotrexate, and explore the clinical value of this treatment. Methods: Sixty cases of ectopic pregnancy admitted to our hospital from March 2016 to September 2016 were randomly divided into observation group (n = 30) and control group (n = 30) Group received mifepristone combined methotrexate conservative treatment; control group methotrexate conservative treatment. Results: In the observation group, 28 cases were effective and 2 cases were ineffective. The effective rate was 93.3% (28/30) in the control group, 20 cases in the control group and 10 cases in the invalid group. The effective rate was 66.7% (20/30) in the observation group and the control group The difference was statistically significant (p <0.05). Conclusion: The conservative treatment of mifepristone and methotrexate for the clinical treatment of ectopic pregnancy, significantly enhance the efficacy, has a high value, worthy of clinical application.